Knowledge Centre
comparison

Top vendors for Decision Support, compared

Six vendors across clinical surveillance, oncology diagnostics, trial data management, wearable analytics, screening infrastructure, and assay development — who does what, and for whom.

April 29, 2026· 4 min read· AI-generated

Top vendors for Decision Support, compared

Six vendors across clinical surveillance, oncology diagnostics, trial data management, wearable analytics, screening infrastructure, and assay development — who does what, and for whom.

TL;DR

"Decision support" in healthcare covers a lot of ground. The six vendors here sit at very different points on the care and research continuum, so this comparison is less about ranking and more about matching the right tool to the right problem.

AirStrip Technologies, Inc. is the only vendor built for real-time bedside clinical surveillance — consolidating EMR, monitor, and device data into mobile alerts for ICU, ED, and OB teams. Guardant Health, Inc. delivers oncology decision support through FDA-approved liquid biopsy tests used by 12,000+ physicians. Simple HealthKit targets population health, giving health plans and public health agencies CLIA-certified screening infrastructure to close HEDIS gaps fast. Medidata Solutions, Inc. (a Dassault Systèmes company) and VivoSense Inc. both serve clinical trial ecosystems — Medidata as a broad cloud-based trial management platform, VivoSense as a specialist in wearable sensor data. ResearchDx, Inc. operates furthest upstream: it's a CRO that develops, validates, and manufactures the diagnostic assays that eventually feed decision support tools downstream.

At a glance

VendorPrimary decision supportedPrimary customerCare settingKey accreditation / standard
ResearchDx, Inc.IVD assay development & validationPharma, biotech, device developersLab / CROCLIA, CAP, ISO 15189, ISO 13485:2016
AirStrip Technologies, Inc.Real-time clinical surveillance & alarm managementHospitals, health systemsICU, ED, OB, Cardiology
Guardant Health, Inc.Oncology treatment & cancer screening decisionsOncologists, health systems, biopharmaClinical lab / outpatientFDA-approved tests (Shield, Guardant360 CDx)
VivoSense Inc.Wearable sensor data for clinical trialsPharma sponsors, CROsClinical research / trials
Medidata Solutions, Inc.Trial data management & study oversightPharma sponsors, CROs, research sitesClinical research / trials
Simple HealthKitPreventive care screening & HEDIS gap closureHealth plans, public health agencies, retail pharmacyPopulation health / remoteCLIA

How they compare

Clinical care vs. research infrastructure

The sharpest divide here is whether a vendor supports active patient-care decisions or the research and manufacturing pipelines that eventually enable those decisions.

On the clinical side: AirStrip pulls data from EMRs, bedside monitors, and connected devices into a single view — up to 40 patients per screen — and delivers diagnostic-quality 12-lead ECG waveforms with STEMI notifications directly to clinicians' phones. That's a capability no other vendor in this group addresses. Guardant Health also operates in active care: its Shield blood test holds FDA approval for colorectal cancer screening, and its Guardant360 CDx test is an FDA-approved companion diagnostic for treatment selection in advanced cancer. With 500,000+ tests performed, this isn't a pilot program — it's an established clinical workflow. Simple HealthKit takes a third clinical angle: not acute care, but population-level preventive screening. Its CLIA-certified lab infrastructure pairs with digital patient engagement tools, and health plan customers can typically go live within weeks rather than months.

ResearchDx, VivoSense, and Medidata are research-infrastructure plays. ResearchDx develops custom molecular assays (PCR, qPCR, and others) and manufactures kits under ISO 13485:2016 and GMP requirements — it builds what goes inside a diagnostic product, not an end-user decision interface. VivoSense manages wearable sensor strategy, device selection, and data pipelines for clinical trials across 20+ therapeutic areas in 30+ countries. Medidata offers the broadest platform of the three: cloud-based electronic data capture, patient engagement, data management, and regulatory submissions, now owned by Dassault Systèmes and deployed across hundreds of global trial programs.

Regulatory and accreditation footprint

If compliance is part of your evaluation criteria, the accreditation profiles diverge meaningfully. ResearchDx carries the most extensive stack in this group: CLIA, CAP, ISO 15189 for clinical testing, and ISO 13485:2016 for device manufacturing. Simple HealthKit holds CLIA certification for its laboratory operations. Guardant Health's FDA approvals on Shield and Guardant360 CDx are the relevant credential there — those tests have cleared the regulatory bar required for clinical decision-making in cancer screening and companion diagnostics.

AirStrip, VivoSense, and Medidata are software platforms. Their compliance posture involves data security frameworks and interoperability standards rather than laboratory accreditation, though the vendor data provided doesn't specify certifications for these three.

Pricing note: None of the six vendors publish standard rate cards. Contract-specific pricing applies across the board.

How to choose

The right vendor depends almost entirely on where in the care and research continuum your gap sits.

  • Hospital or health system needing bedside clinical surveillance across ICU, ED, or OB: AirStrip is the only vendor here built for that setting.
  • Oncology treatment decisions or cancer screening programs: Guardant Health — its FDA-approved tests are already in active clinical use at scale.
  • Health plan, payer, or public health agency closing HEDIS gaps or standing up preventive screening quickly: Simple HealthKit is purpose-built for that

Sources

Browse vendors in

Vendors discussed

MedSource publishes neutral guidance. We do not accept payment from vendors to influence the content of articles. AI-generated articles are reviewed for factual accuracy but cited sources should be the primary reference for procurement decisions.